Repositorio Dspace
Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice
JavaScript is disabled for your browser. Some features of this site may not work without it.
Mostrar el registro sencillo del ítem
| dc.contributor.author | García-Gutiérrez, Valentín | |
| dc.contributor.author | Luna, Alejandro | |
| dc.contributor.author | Alonso-Domínguez, Juan-Manuel | |
| dc.contributor.author | Estrada, Natalia | |
| dc.contributor.author | Boque, Concepción | |
| dc.contributor.author | Xicoy, Blanca | |
| dc.contributor.author | Giraldo, Pilar | |
| dc.contributor.author | Angona, Anna | |
| dc.contributor.author | Álvarez-Larrán, Alberto | |
| dc.contributor.author | Sánchez-Guijo, Fermín | |
| dc.contributor.author | Ramírez, María-José | |
| dc.contributor.author | Mora, Elvira | |
| dc.contributor.author | Vélez, Patricia | |
| dc.contributor.author | Rosell, Ana | |
| dc.contributor.author | Colorado-Araujo, Mercedes | |
| dc.contributor.author | Cuevas, Beatriz | |
| dc.contributor.author | Sagüés, Miguel | |
| dc.contributor.author | Cortés, Montserrat | |
| dc.contributor.author | Pérez-Encinas, Manuel-Mateo | |
| dc.contributor.author | Casado-Montero, Luis-Felipe | |
| dc.contributor.author | Moreno-Vega, Melania | |
| dc.contributor.author | Serrano, Luis | |
| dc.contributor.author | Gómez, Valle | |
| dc.contributor.author | García-Hernández, Carmen | |
| dc.contributor.author | Lakhwani, Sunil | |
| dc.contributor.author | Paz-Coll, Antonio | |
| dc.contributor.author | de-Paz, Raquel | |
| dc.contributor.author | Suárez-Varela, Sara | |
| dc.contributor.author | Fernández-Ruiz, Andrés | |
| dc.contributor.author | Pérez-López, Raúl | |
| dc.contributor.author | Ortiz-Fernández, Almudena | |
| dc.contributor.author | Jiménez-Velasco, Antonio | |
| dc.contributor.author | Steegmann-Olmedillas, Juan-Luis | |
| dc.contributor.author | Hernández-Boluda, Juan-Carlos | |
| dc.date.accessioned | 2025-12-03T11:18:33Z | |
| dc.date.available | 2025-12-03T11:18:33Z | |
| dc.date.issued | 2021 | |
| dc.identifier.citation | Garcia-Gutiérrez V, Luna A, Alonso-Dominguez JM, Estrada N, Boque C, Xicoy B, et al. Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice. Blood Cancer J. 9 de febrero de 2021;11(2):16. | |
| dc.identifier.issn | 2044-5385 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/23103 | |
| dc.language.iso | eng | |
| dc.publisher | Springer Nature | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | * |
| dc.subject.mesh | Adult | |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Aged, 80 and over | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Fusion Proteins, bcr-abl/antagonists & inhibitors | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Niacinamide/adverse effects/analogs & derivatives/therapeutic use | |
| dc.subject.mesh | Protein Kinase Inhibitors/adverse effects/therapeutic use | |
| dc.subject.mesh | Pyrazoles/adverse effects/therapeutic use | |
| dc.subject.mesh | Treatment Outcome | |
| dc.subject.mesh | Young Adult | |
| dc.title | Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 33563899 | |
| dc.relation.publisherversion | https://www.nature.com/articles/s41408-021-00420-8 | |
| dc.identifier.doi | 10.1038/s41408-021-00420-8 | |
| dc.journal.title | Blood Cancer Journal |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional